[ad_1]
Taipei, July 27, 2021 /PRNewswire/ – TCI Probiotic Science Japan Is the first in the industry to isolate Lactobacillus TCI 378 from kimchi, through a proprietary extraction and “amplification” process, the number of probiotics that could only be consumed by ingesting a large amount of kimchi in the past is now integrated into a small amount of dietary supplement to “beneficial bacteria”. It can be easily transported to the intestine. TCI Japan’s R&D team successfully confirmed in a study that TCI 378 has the ability to resist acid and bile salts, so it can successfully colonize the intestine even through gastric acid and the digestive tract, and TCI 378 and Its metabolites can reduce fat formation, increase fat metabolism, help cholesterol metabolism, and improve gastrointestinal function. The study was published in the international journal Preventive Nutrition and Food Science in 2019. In the same year, TCI 378 won the Silicon Valley International Invention Award Bronze Award. U.S. So far, TCI 378 has been patented in many countries and is a…
The full story on Benzinga.com
[ad_2]
Source link
